Steven S. Good
Atea Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Biochemical and Molecular Research, Hepatitis C virus research, HIV Research and Treatment, Cytomegalovirus and herpesvirus research
Most-Cited Works
- → Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.(1994)420 cited
- → 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity(1997)385 cited
- → Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of Action(2002)362 cited
- In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.(1993)
- → Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89(1997)223 cited
- → AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19(2021)132 cited